Author

E. Ben-Chetrit

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Jarjoui· 1 shared A. Levy-Barda· 1 shared A. Peretz· 1 shared A. Tzankov· 1 shared B. Brenner· 1 shared C. Zinner· 1 shared D. Reichmann· 1 shared E. Orenbuch-Harroch· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Jarjoui

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Altered somatic hypermutation patterns in COVID-19 patients classifies disease severity

M. Safra, Z. Tamari, P. Polak, S. Shiber, M. Matan, H. Karameh, Y. Helviz, A. Levy-Barda, V. Yahalom, A. Peretz, E. Ben-Chetrit, B. Brenner, T. Tuller, M. Gal-Tanamy, G. Yaari

This study uses machine learning to analyze B cell receptor sequencing data and identifies altered somatic hypermutation patterns in COVID-19 patients that correlate with disease severity.

bioRxiv · Dec 20, 2022 · PreprintImmunology

COVID-19 patients have increased levels of membrane-associated and soluble CD48

H. Pahima, I. Zaffran, E. Ben-Chetrit, A. Jarjoui, P. Gaur, M. L. Manca, D. Reichmann, E. Orenbuch-Harroch, I. Puxeddu, C. Zinner, A. Tzankov, F. Levi-Schaffer

The paper finds increased levels of membrane-bound and soluble CD48 in COVID-19 patients through various assays, suggesting a potential therapeutic target.

bioRxiv · Mar 18, 2022 · PreprintImmunology